News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Regulatory News - September 2020Regulatory News - September 2020Press release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyRegulatory news - August 2020Regulatory news - August 2020Regulatory news - July 2020Regulatory news - July 2020Regulatory news - June 2020Regulatory news - June 2020Regulatory news - May 2020Regulatory news - May 2020Regulatory news - April 2020Regulatory news - April 2020Regulatory news - March 2020Regulatory news - March 2020Regulatory news - February 2020Regulatory news - February 2020Regulatory news - January 2020Regulatory news - January 2020Regulatory news - December 2019Regulatory news - December 2019Regulatory news - November 2019Regulatory news - November 2019